Skip to content

Randomised controlled trial evaluating the efficacy of prebiotics, probiotics and synbiotics in chronic constipation; A pilot study

Randomised controlled trial evaluating the efficacy of prebiotics, probiotics and synbiotics in chronic constipation; A pilot study - Randomised controlled trial evaluating the efficacy of prebiotics, probiotics and synbiotics in chronic constipation; A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027429
Enrollment
40
Registered
2017-06-01
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation

Interventions

Control arm: nutritional guidance only Prebiotics arm: water soluble dietary fiber intake 10g/day for 4 weeks following nutritional guidance Probiotics arm: Bifidobacterium longum BB536 (1*10(11) CFU/

Sponsors

Tsujinaka Hospital Kashiwanoha
Lead Sponsor
Clinical Study Support Center, Wakayama Medical University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Chronic Constipation 1)Must include 2 or more of the followings 1. Fewer than 3 spontaneous bowel movements per week 2. Straining during more than one-fourth of defecations 3. Lumpy of hard stool (BSFS1-2) more than one-fourth of defecations 4. Sensation of incomplete evacuation more than one-fourth of defecations 5. Sensation of anorectal obstruction/blockage more than one-fourth of defecations 6. Manual maneuvers to facilitate more than one-fourth of defecations 2) Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis 3) Loose stools are rarely present without the use of laxatives Chronic constipation is diagnosed if patients meet criteria 1), 2), and 3).

Exclusion criteria

Exclusion criteria: 1) rectal intussuspocion, rectal prolapse, and megacolon inducing constipation 2) secondary constipation due to psychiatric disorders, neurologic disorders, endcrine disorders, or medication (opioids, antidepressants, anticholinergic, calcium channel blockers, proton pump inhibitors) 3)mechanical obstruction 4)past history of inflammatory bowel diseases, colorectal cancer, or bowel obstruction 5)pregnant of lactating woman 6)renal failure (serum Cr>=2.0mg/dl), severe liver disorder (T-Bil >=3.0mg/dl or AST, ALT>=100U/L) 7)severe cardiovascular disorders 8)physician determined ineligible

Design outcomes

Primary

MeasureTime frame
complete spontaneous bowel movement compared baseline and 4weeks of treatments

Secondary

MeasureTime frame
spontaneous bowel movement, Bristol Stool Form Scale, Constipation Scoring System (CSS), The Patient Assesment of Constipation Quality of Life (PAC-QOL), Gastrointestinal Symptoms Rating Scale (GSRS), evacuation symptoms (straining, sensation of incomplete evacuation, pain, and satisfaction), and amount of dietary fiber intake per day after 4weeks of treatments

Countries

Japan

Contacts

Public ContactTakafumi Maeda

Tsujinaka Hospital Kashiwanoha Department of Surgery

takafumim@hotmail.com0471-37-3737

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026